The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women

Journal of Translational Medicine

Volumn 14, Issue 1, 2016, Pages

  Xia, Ming Feng ^a   Lin, Huan Dong ^a   Yan, Hong Mei ^a   Bian, Hua ^a   Chang, Xin Xia ^a   Zhang, Lin Shan ^a   He, Wan Yuan ^a   Gao, Xin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Alanine aminotransferase; Bone mineral density; Liver fat content; NAFLD; Osteocalcin

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY REGIONS; BONE DENSITY; BONE METABOLISM; CHINESE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIGH RISK PATIENT; HIP; HUMAN; LIVER FAT CONTENT; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NUTRITIONAL PARAMETERS; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; RISK FACTOR; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; DEMOGRAPHY; LIVER; METABOLISM; MIDDLE AGED; OBESITY; STATISTICAL MODEL; VERY ELDERLY;

ADIPOSITY; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; BONE DENSITY; CHINA; DEMOGRAPHY; FEMALE; HUMANS; LINEAR MODELS; LIVER; MALE; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS;

EID: 84958888896     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-016-0766-3     Document Type: Article

References (45)

1. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008;48(Suppl 1):S104-12.
2. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;25:883-9.
3. Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology. 2012;142:711-25.
4. Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2007;30:2940-4.
5. Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014;11(7):e1001680.
6. Treeprasertsuk S, Leverage S, Adams LA, Lindor KD, St Sauver J, Angulo P. The Framingham risk score and heart disease in nonalcoholic fatty liver disease. Liver Int. 2012;32:945-50.
7. Cobbold JF, Anstee QM, Taylor-Robinson SD. The importance of fatty liver disease in clinical practice. Proc Nutr Soc. 2010;69:518-27.
8. Yki-Järvinen H. Ectopic fat accumulation: an important cause of insulin resistance in humans. J R Soc Med. 2002;95:39-45.
9. Cooper C. Epidemiology of osteoporosis. Osteoporos Int. 1999;9:S2-8.
10. Kawai M, Rosen CJ. Bone: adiposity and bone accrual-still an established paradigm? Nat Rev Endocrinol. 2010;6:63-4.
11. Musso G, Paschetta E, Gambino R, Cassader M, Molinaro F. Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. Trends Mol Med. 2013;19:522-35.
12. Pardee PE, Dunn W, Schwimmer JB. Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment Pharmacol Ther. 2012;35:248-54.
13. Moon SS, Lee YS, Kim SW. Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine. 2012;42:423-9.
14. Cui R, Sheng H, Rui XF, Cheng XY, Sheng CJ, Wang JY, et al. Low bone mineral density in chinese adults with nonalcoholic Fatty liver disease. Int J Endocrinol. 2013;2013:396545.
15. Li M, Xu Y, Xu M, Ma L, Wang T, Liu Y, et al. Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J Clin Endocrinol Metab. 2012;97(6):2033-8.
16. Xia MF, Yan HM, He WY, Li XM, Li CL, Yao XZ, et al. Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method. Obesity. 2012;20:444-52.
17. Gao X, Hofman A, Hu Y, Lin H, Zhu C, Jeekel J, et al. The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: Objectives and design. Eur J Epidemiol. 2010;25:885-93.
18. Farrell GC, Chitturi S, Lau GK, Sollano JD. Asia-Pacific working party on NAFLD. Guidelines for the assessment and management of nonalcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol. 2007;22:775-7.
19. Douchi T, Yamamoto S, Oki T, Maruta K, Kuwahata R, Nagata Y. Relationship between body fat distribution and bone mineral density in premenopausal Japanese women. Obstet Gynecol. 2000;95(5):722-5.
20. Li X, Xia M, Ma H, Hofman A, Hu Y, Yan H, et al. Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: the Shanghai Changfeng study. Atherosclerosis. 2012;224:480-5.
21. Xia MF, Bian H, Yan HM, Lin HD, Chang XX, Li XM, et al. Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases. Obesity (Silver Spring). 2015;23(9):1929-37.
22. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461-70.
23. Cui LH, Shin MH, Kweon SS, Choi JS, Rhee JA, Lee YH, et al. Sex-related differences in the association between waist circumference and bone mineral density in a Korean population. BMC Musculoskelet Disord. 2014;15:326.
24. Mazess RB, Barden HS, Drinka PJ, Bauwens SF, Orwoll ES, Bell NH. Influence of age and body weight on spine and femur bone mineral density in U.S. white men. J Bone Miner Res. 1990;5(6):645-52.
25. Koller DL, Zheng HF, Karasik D, Yerges-Armstrong L, Liu CT, McGuigan F, et al. Meta-analysis of genome-wide studies identifies WNT16 and ESR1 SNPs associated with bone mineral density in premenopausal women. J Bone Miner Res. 2013;28(3):547-58.
26. Chen Z, Salam MT, Karim R, Toledo-Corral CM, Watanabe RM, Xiang AH, et al. Living near a freeway is associated with lower bone mineral density among Mexican Americans. Osteoporos Int. 2015;26(6):1713-21.
27. Noordzij M, Dekker FW, Zoccali C, Jager KJ. Sample size calculations. Nephron Clin Pract. 2011;118:c319-23.
28. Power MJ, Fottrell PF. Osteocalcin: diagnostic methods and clinical applications. Crit Rev Clin Lab Sci. 1991;28:287-335.
29. Bhupathiraju SN, Dawson-Hughes B, Hannan MT, Lichtenstein AH, Tucker KL. Centrally located body fat is associated with lower bone mineral density in older Puerto Rican adults. Am J Clin Nutr. 2011;94(4):1063-70.
30. Liu YH, Xu Y, Wen YB, Guan K, Ling WH, He LP, et al. Association of weight-adjusted body fat and fat distribution with bone mineral density in middle-aged chinese adults: a cross-sectional study. PLoS One. 2013;8(5):e63339.
31. Zhou J, Zhang Q, Yuan X, Wang J, Li C, Sheng H, et al. Association between metabolic syndrome and osteoporosis: a meta-analysis. Bone. 2013;57:30-5.
32. Herrmann M, Seibel MJ. The amino- and carboxyterminal cross-linked telopeptides of collagen type I: a comparative review. Clin Chim Acta. 2008;393:5757-75.
33. Fulzele K, Riddle RC, DiGirolamo DJ, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010;142(2):309-19.
34. Yilmaz Y. Review article: non-alcoholic fatty liver disease and osteoporosis-clinical and molecular crosstalk. Aliment Pharmacol Ther. 2012;36:345-52.
35. Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alphaA) is inhibited by tumor necrosis factor alpha. J Biol Chem. 2002;277:2695-701.
36. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17(7):517-24.
37. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92:4-8.
38. Wong VW, Wong GL, Tsang SW, Hui AY, Chan AW, Choi PC, et al. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Aliment Pharmacol Ther. 2009;29(4):387-96.
39. Kerner A, Avizohar O, Sella R, Bartha P, Zinder O, Markiewicz W, et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2005;25:193-7.
40. Yamada J, Tomiyama H, Yambe M, Koji Y, Motobe K, Shiina K, et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis. 2006;189:198-205.
41. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab. 2008;93:1952-8.
42. Zhang YB, Zhong ZM, Hou G, Jiang H, Chen JT. Involvement of oxidative stress in age-related bone loss. J Surg Res. 2011;169:e37-42.
43. Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC. Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci U S A. 1991;88(15):6613-7.
44. Föger-Samwald U, Patsch JM, Schamall D, Alaghebandan A, Deutschmann J, Salem S, et al. Molecular evidence of osteoblast dysfunction in elderly men with osteoporotic hip fractures. Exp Gerontol. 2014;57:114-21.
45. Franklin RM, Ploutz-Snyder L, Kanaley JA. Longitudinal changes in abdominal fat distribution with menopause. Metabolism. 2009;58(3):311-5.